(Q46157979)

20 December 2017

title

Prognostic significance of the Bcl-2 negative germinal centre in patients with diffuse large B cell lymphoma treated with R-CHOP. (English)

1 reference

20 December 2017

author name string

Moo-Kon Song

1

1 reference

20 December 2017

Joo-Seop Chung

2

1 reference

20 December 2017

Dong-Hoon Shin

3

1 reference

20 December 2017

Young-Mi Seol

4

1 reference

20 December 2017

Ho-Jin Shin

5

1 reference

20 December 2017

Young-Jin Choi

6

1 reference

20 December 2017

Goon-Jae Cho

7

1 reference

20 December 2017

publication date

1 January 2009

1 reference

20 December 2017

published in

Leukemia & Lymphoma

1 reference

20 December 2017

volume

50

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

54-61

1 reference

20 December 2017

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Identification of a high-risk subset with coexpression of CD10 and bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802626616

10.1080/10428190802626616

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017